Navigation Links
Cancer theory stands the test of time -- rediscovering Boveri a century later
Date:2/29/2008

COLD SPRING HARBOR, N.Y. Rarely has a book in the biological sciences proved as prescient as Theodor Boveris 1914 monograph Concerning the Origin of Malignant Tumours. Out of print for decades and previously almost impossible to track down, the book is now available as a new and authoritative translation, co-published by Cold Spring Harbor Laboratory Press and The Company of Biologists.

Concerning the Origin of Malignant Tumours had a huge impact on cancer research. In it, Boveri was the first to argue that cancer is caused by defects in chromosomes and that these can be caused by a failure of cells to divide properly. He also proposed that the cells natural urge is to divide and that it is held in check by specific mechanisms that prevent cancer almost a hundred years later we know this to be true, having identified so-called tumor suppressors like the retinoblastoma protein. Perhaps most astonishingly, Boveri also predicted the existence of genes, suggesting that hereditary characters are aligned along chromosomes in a specific order.

Regularly quoted and frequently misquoted the only English version of Concerning the Origin of Malignant Tumours ever available before was a rare translation by Boveris wife, who was not a biologist. The new translation is by Sir Henry Harris, Regius Professor of Medicine at Oxford University, and includes extensive annotations in which Harris discusses the relevance of Boveris views today.

Reviewing the book, leading geneticist Felix Mitelman wrote that he cannot find superlatives enough to praise the lucid text, adding that the annotations contain words of wisdom that I wish could be made compulsory reading.


'/>"/>

Contact: Ingrid Benirschke
benirsch@cshl.edu
619-275-6021
Cold Spring Harbor Laboratory
Source:Eurekalert  

Page: 1

Related medicine news :

1. When couples face the diagnosis of cancer, women carry a larger emotional burden than men
2. Vitamin E Supplements May Raise Lung Cancer Risk
3. Certain vitamin supplements may increase lung cancer risk, especially in smokers
4. New study of targeted therapies for breast cancer -- model for global clinical trials
5. Broccoli Sprout Extract Hinders Bladder Cancer Development
6. Heart Hormones Beat Back Cancers in Mice
7. Cancer-related protein may play key role in Alzheimers disease
8. Weill Cornell team identifies potential new drug targets against hormone-dependent breast cancer
9. Atypical protein kinase C stabilizes SRC-3 levels in breast cancer cells
10. Breast cancer death rates among black women not decreasing across all states
11. Scientists Find Cancer Culprits in Cigarette Smoke
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer theory stands the test of time -- rediscovering Boveri a century later
(Date:3/27/2017)... ... 27, 2017 , ... Adding to its expanding portfolio of ... and NEJM Journal Watch, announces the release of NEJM Knowledge+ Pediatrics Board ... of pediatricians from leading medical centers. The content was then reviewed and approved ...
(Date:3/27/2017)... Birmingham, Clarkston, and Lake Orion, Michigan (PRWEB) , ... ... ... can affect weight loss results. The comprehensive weight management program at Women’s ... begins with an initial evaluation and physical exam. The specialists at ...
(Date:3/27/2017)... ... March 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 ... had in a long time,” she said. , She thinks the coming week is going ... never thought I would have to help my students.” , The award will allow the ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... a settlement agreement to resolve the pending litigation between itself and 1800 Vending ... District of Utah). , “I am thrilled to announce that we have now ...
(Date:3/26/2017)... (PRWEB) , ... March 26, 2017 , ... ... worldwide to receive the RealSelf 100 Award, a prestigious award honoring the top ... procedures and to find and connect with doctors and clinics. , In 2016, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. (NASDAQ: ... life-threatening inherited liver diseases in children, today reported ... year ended December 31, 2016 and provided an ... "PhaseRx continued to make progress during the fourth ... results from our non-human primate safety study, and with ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Manufacturing Market, 2017-2027" report to their offering. ... The Cell Therapy ... rapidly growing market of cell therapy manufacturing and focuses both ... facilities. These therapies are anticipated to emerge as viable alternatives ...
(Date:3/24/2017)... March 24, 2017  Zymo Research Corp., ... Hamilton Robotics, Inc., who designs, manufactures and ... collaboration that teams Zymo Research,s DNA methylation ... DNA extraction products with Hamilton,s high-throughput automation ... methods for microbiomics and RNA isolation for ...
Breaking Medicine Technology: